Adaptive Versus Non-adaptive Radiotherapy and 2 Bladder Filling Instructions for Patients With Intermediate or High Risk Localized Prostate Cancer (ARP)

The study is being done to compare the side effects between two different radiation techniques, standard non-adaptive radiation therapy vs. daily adaptive radiation therapy and also comparing two different bladder filling instructions to find out if customized bladder instructions may lead to better treatment outcomes.

Trial Details

NCT ID
NCT06678126
Phase
PHASE2
Sponsor
Scott Tyldesley
Status
RECRUITING
Cancer Type
Prostate Cancer
Interventions
  • Prostate and Pelvic Nodes Radiotherapy
Locations (sample)
  • Vancouver, British Columbia, Canada|49.24966,-123.11934

Key Eligibility Criteria

  • Pathological diagnosis of a primary prostate adenocarcinoma
  • NCCN Intermediate or high risk localized prostate cancer and clinically N0 and M0 by conventional imaging
  • Intermediate: one or more of cT2b-T2c, PSA 10-20, or Gleason Group 2 or 3
  • High: one or more of: cT3a, PSA \> 20, or Gleason Group 4 or 5.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Prostate Cancer Trials on Trialify →